Tag Archives: Kneeland C. Youngblood

Capitalisation Pro Kneeland C. Youngblood joins Scientific Games governance

Nasdaq-listed industry technology group Scientific Games Corporation (SGC), has expanded its governance committee, confirming the appointment of Kneeland C. Youngblood as a new company director. An expert in large-scale financing projects, corporate recapitalisation and political stakeholder management, Youngblood will serve as an SGC advisor and member of the Nasdaq enterprises’ compensation and compliance committees. A qualified physician, Youngblood is the …

Read More »